Amgen Presents New Data From Phase 3 Study Of Talimogene Laherparepvec In Patients With Metastatic Melanoma Read more about Amgen Presents New Data From Phase 3 Study Of Talimogene Laherparepvec In Patients With Metastatic Melanoma
Amgen and Onyx Pharmaceuticals Announce Early Termination of HSR Waiting Period for Amgen's Acquisition of Onyx Read more about Amgen and Onyx Pharmaceuticals Announce Early Termination of HSR Waiting Period for Amgen's Acquisition of Onyx
Amgen Highlights Data To Be Presented At 2013 European Cancer Congress Read more about Amgen Highlights Data To Be Presented At 2013 European Cancer Congress
Analysis Published In New England Journal of Medicine Highlights Discovery Of New Predictive Biomarkers For Vectibix® (Panitumumab) Read more about Analysis Published In New England Journal of Medicine Highlights Discovery Of New Predictive Biomarkers For Vectibix® (Panitumumab)
Amgen To Present At The Bank Of America Merrill Lynch Global Healthcare Conference Read more about Amgen To Present At The Bank Of America Merrill Lynch Global Healthcare Conference
Amgen To Present At The Morgan Stanley Global Healthcare Conference Read more about Amgen To Present At The Morgan Stanley Global Healthcare Conference
Amgen And Cytokinetics Announce The First Presentation Of Data From Phase 2 ATOMIC-AHF Study Of Omecamtiv Mecarbil Read more about Amgen And Cytokinetics Announce The First Presentation Of Data From Phase 2 ATOMIC-AHF Study Of Omecamtiv Mecarbil
Amgen Presents Pooled Analysis Showing AMG 145 Significantly Reduced LDL Cholesterol In Over 1,200 Patients Read more about Amgen Presents Pooled Analysis Showing AMG 145 Significantly Reduced LDL Cholesterol In Over 1,200 Patients
Amgen To Participate At Citi's 8th Annual Biotech Conference Read more about Amgen To Participate At Citi's 8th Annual Biotech Conference
Amgen to Highlight New Data at Upcoming ESC Congress 2013 Read more about Amgen to Highlight New Data at Upcoming ESC Congress 2013
